"Leach" cell matrix Aqipei blood cell isolation group (joint injection) - Taiwan Registration 5adde89190595118053a1fdc8c175070
Access comprehensive regulatory information for "Leach" cell matrix Aqipei blood cell isolation group (joint injection) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number 5adde89190595118053a1fdc8c175070 and manufactured by REGEN LAB SA. The authorized representative in Taiwan is QUALTECH CONSULTING CORPORATION.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Product Details
This product consists of multiple sterile and pyrogen-free collection tubes and is designed to prepare a mixture of platelet thick solution (PRP) and hyaluronic acid (HA), 3 ml of platelet thick solution (PRP) corresponds to 2 ml of hyaluronic acid (HA). Each box includes 3 A-CP-HA blood collection tubes in individual plastic packaging. For the preparation of intra-articular injections for the treatment of knee pain, such as grade I to III knee osteoarthritis. It is recommended to inject one tube per injection for a total of three injections, each with two weeks apart.
N ้ชจ็งๅญธ;; B ่กๆถฒๅญธใ็ ็ๅญธๅๅบๅ ๅญธ
N.0003 Articular filler implants; B.9245 Automated hemocytoseparator
import
Dates and Status
Jun 10, 2019
Jun 10, 2029